Corbus Pharmaceuticals Holdings Inc
Change company Symbol lookup
Select an option...
CRBP Corbus Pharmaceuticals Holdings Inc
PTI Proteostasis Therapeutics Inc
CALB California BanCorp
$NOPM2 Refinitiv Norway Metal & Mining Inde
EBAY eBay Inc
PTON Peloton Interactive Inc
GO Grocery Outlet Holding Corp
NUE Nucor Corp
SJM J M Smucker Co
KR Kroger Co
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and halt fibrotic processes. Lenabasum stimulates the production of Specialized Pro-Resolving Lipid Mediators (SPMs) that act to resolve inflammation, and halt fibrosis by activating endogenous pathways. The Company is developing lenabasum to treat four diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis and systemic lupus erythematosus (SLE).

Postmarket

Last Trade
Delayed
$1.20
-0.02 (-1.64%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$1.22
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.26
Day's Low
1.18
Volume
(Light)
Volume:
3,095,769

10-day average volume:
4,789,899
3,095,769

CLASS ACTION UPDATE for STAA, BLNK and PLAN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

6:35 am ET October 19, 2020 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

STAA Shareholders Click Here: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=10253&wire=1BLNK Shareholders Click Here: https://www.zlk.com/pslra-1/blink-charging-company-information-request-form?prid=10253&wire=1PLAN Shareholders Click Here: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=10253&wire=1

* ADDITIONAL INFORMATION BELOW *

Staar Surgical Company (NASDAQ: STAA)

STAA Lawsuit on behalf of: investors who purchased February 26, 2020 - August 10, 2020Lead Plaintiff Deadline : October 19, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/staar-surgical-company-information-request-form?prid=10253&wire=1

According to the filed complaint, during the class period, Staar Surgical Company made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.

Blink Charging Company (NASDAQ: BLNK)

BLNK Lawsuit on behalf of: investors who purchased March 6, 2020 - August 19, 2020Lead Plaintiff Deadline : October 23, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/blink-charging-company-information-request-form?prid=10253&wire=1

According to the filed complaint, during the class period, Blink Charging Company made materially false and/or misleading statements and/or failed to disclose that: (i) many of Blink's charging stations are damaged, neglected, non-functional, inaccessible, nor non-accessible; (ii) Blink's purported partnerships and expansions with other companies were overstated; (iii) the purported growth of the Company's network has been overstated; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Anaplan Inc. (NYSE: PLAN)

PLAN Lawsuit on behalf of: investors who purchased November 21, 2019 - February 26, 2020Lead Plaintiff Deadline : October 23, 2020TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/anaplan-inc-information-request-form?prid=10253&wire=1

According to the filed complaint, during the class period, Anaplan Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.55 Broadway, 10th FloorNew York, NY 10006jlevi@levikorsinsky.comTel: (212) 363-7500Fax: (212) 363-7171www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com: https://www.accesswire.com/611012/CLASS-ACTION-UPDATE-for-STAA-BLNK-and-PLAN-Levi-Korsinsky-LLP-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.